Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate and Monitor and Report Trading by Insiders, Oxygenta Pharmaceutical has informed that the Trading Window for transactions in Securities of the Company for all Designated Persons and their immediate relatives will be closed from Tuesday, April 01,2025 till 48 hours after the declaration of Audited Financial Results of the Company for the Fourth quarter and Financial Year ending March 31, 2025. The date of Board Meeting for the consideration of Audited Financial Results of the Company for the Fourth quarter and Financial Year ending March 31, 2025 will be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
